Literature DB >> 3981636

Regulation of growth hormone messenger RNA synthesis by dexamethasone and triiodothyronine. Transcriptional rate and mRNA stability changes in pituitary tumor cells.

D J Diamond, H M Goodman.   

Abstract

We have characterized the process by which the growth hormone (GH) gene is stimulated in rat pituitary tumor cells (GC or GH3) by the steroid hormone dexamethasone (Dex) and the thyroid hormone, L-triiodothyronine (T3). A primary transcriptional response is detected within 60 minutes of addition of T3 or Dex + T3 to GH-producing cells (GC or GH3). A fivefold transcriptional stimulation of GH nuclear RNA occurs in cells cultured with serum substitute medium and induced with Dex + T3, while T3 alone induces a modest two- to threefold stimulation. The absence of fetal calf serum from the cell culture medium does not decrease the level of transcriptional activity of the GH gene during hormone stimulation. Twenty-four hours after addition of Dex + T3 the cytoplasmic GH mRNA shows a 50-fold increase, as measured by S1 nuclease analysis. This large accumulation of cytoplasmic GH mRNA in contrast to the relatively small changes in GH gene activity is inconsistent with solely a transcriptional mechanism of hormone induction. We suggest that a change in specific GH mRNA stability also takes place in response to Dex + T3. In contrast to other reports, transcriptional stimulation of the GH gene by Dex is insignificant except in the presence of T3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981636     DOI: 10.1016/0022-2836(85)90323-7

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

1.  Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.

Authors:  S O Nascif; M H Senger; J C Ramos-Dias; A M J Lengyel
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

Review 2.  Thyroid hormones and growth hormone secretion.

Authors:  R Valcavi; M Zini; I Portioli
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

3.  Molecular cloning of gene sequences regulated during squamous differentiation of tracheal epithelial cells and controlled by retinoic acid.

Authors:  H L Smits; E E Floyd; A M Jetten
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

Review 4.  Neuropeptide gene expression and neural activity: assessing a working hypothesis in nucleus caudalis and dorsal horn neurons expressing preproenkephalin and preprodynorphin.

Authors:  G R Uhl; T Nishimori
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

5.  Mechanisms involved in glucocorticoid induction of pituitary GH expression during embryonic development.

Authors:  Laura E Ellestad; Stefanie A Puckett; Tom E Porter
Journal:  Endocrinology       Date:  2015-01-05       Impact factor: 4.736

6.  Glucocorticoids enhance stability of human growth hormone mRNA.

Authors:  I Paek; R Axel
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

7.  Translational initiation factor expression and ribosomal protein gene expression are repressed coordinately but by different mechanisms in murine lymphosarcoma cells treated with glucocorticoids.

Authors:  S Huang; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

8.  Thyroid hormone receptor binds to a site in the rat growth hormone promoter required for induction by thyroid hormone.

Authors:  R J Koenig; G A Brent; R L Warne; P R Larsen; D D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Insulin regulation of rat growth hormone gene transcription.

Authors:  S Yamashita; S Melmed
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

10.  Glucocorticoids stimulate transcription of the rat phenylethanolamine N-methyltransferase (PNMT) gene in vivo and in vitro.

Authors:  M J Evinger; A C Towle; D H Park; P Lee; T H Joh
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.